| |
 |
|
Class Information
Number: 552/653
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > 9,10-seco-cyclopentanohydrophenanthrene ring system or 9,10-seco cyclopentanohydrophenanthrene ring system having a bond between the 3- and 5-positions (e.g., vitamin d compounds, cholecalciferols, activated 7-dehydrocholesterols, dihydrotachysterols, 3,5 cyclovitamin d compounds, etc.)
Description: Compounds under Class 260, ... , which have the following basic structures:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7563783 |
2-methylene-19-nor-(20S-24S)-1.alpha.,25-dihydroxyvitamin-D.sub.2 |
Jul. 21, 2009 |
| 7541348 |
2-methylene-19-nor-(20S)-1.alpha.-hydroxy-trishomopregnacalciferol |
Jun. 2, 2009 |
| 7541349 |
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone |
Jun. 2, 2009 |
| 7538098 |
19-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ring |
May. 26, 2009 |
| 7534777 |
Des-C,D analogs of 1.alpha.,25-dihydroxy-19-norvitamin D.sub.3 |
May. 19, 2009 |
| 7531527 |
2-Propylidene-19-nor-vitamin D compounds |
May. 12, 2009 |
| 7528122 |
Vitamin D analog--NEL, methods and uses thereof |
May. 5, 2009 |
| 7524980 |
Vitamin D.sub.3 lactam derivative |
Apr. 28, 2009 |
| 7511030 |
2-methylene-19-nor-(20S-24epi)-1.alpha.,25-dihydroxyvitamin D.sub.2 |
Mar. 31, 2009 |
| 7491712 |
Process for preparation of paricalcitol and intermediates thereof |
Feb. 17, 2009 |
| 7491711 |
Methods of treatment using 3-desoxy vitamin D3 analogs |
Feb. 17, 2009 |
| 7402688 |
2,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin D derivative |
Jul. 22, 2008 |
| 7332482 |
Method for treating benign prostatic hyperplasia |
Feb. 19, 2008 |
| 7323580 |
Crystals of a vitamin D derivative and a method for the preparation thereof |
Jan. 29, 2008 |
| 7253293 |
Enzymatic method to produce 7-dehydropregnenolone, vitamin D3-like compounds and derivatives thereof |
Aug. 7, 2007 |
| 7244719 |
2-methylene-19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and its uses |
Jul. 17, 2007 |
| 7241751 |
2.alpha.-methyl-19-nor-(20S)-1.alpha.-hydroxy-bishomopregnacalciferol and its uses |
Jul. 10, 2007 |
| 7241752 |
17,20(E)-dehydro vitamin D analogs and their uses |
Jul. 10, 2007 |
| 7241909 |
19,26,27-trinor-1.alpha.,25-dihydroxyvitamin D.sub.3 compounds |
Jul. 10, 2007 |
| 7241750 |
2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses |
Jul. 10, 2007 |
| 7241747 |
2-propylidene-19-nor-vitamin D compounds |
Jul. 10, 2007 |
| 7241748 |
17,20(Z)-dehydro vitamin D analogs and their uses |
Jul. 10, 2007 |
| 7241749 |
2.alpha.-Methyl and 2.beta.-methyl analogs of 19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and their uses |
Jul. 10, 2007 |
| 7238681 |
2-Methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses |
Jul. 3, 2007 |
| 7235680 |
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone |
Jun. 26, 2007 |
| RE39706 |
Crystalline form of a vitamin D analogue |
Jun. 26, 2007 |
| 7232810 |
2-methylene-19-nor-vitamin D2 compounds |
Jun. 19, 2007 |
| 7214670 |
Use of 2-methylene-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to increase the life expectancy of human beings |
May. 8, 2007 |
| 7214671 |
Use of 2-methylene-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D.sub.3 for the prophylaxis of bone diseases |
May. 8, 2007 |
| 7211680 |
Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
May. 1, 2007 |
| 7208484 |
Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol |
Apr. 24, 2007 |
| 7205286 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D.sub.3 and their uses |
Apr. 17, 2007 |
| 7205420 |
Epimerization of analogs of vitamin D |
Apr. 17, 2007 |
| 7166585 |
24-Sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin D.sub.3 |
Jan. 23, 2007 |
| 7115758 |
Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
Oct. 3, 2006 |
| 7112579 |
26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds |
Sep. 26, 2006 |
| 7101865 |
24-sulfoximine vitamin D3 compounds |
Sep. 5, 2006 |
| 7094775 |
Method of treating breast cancer using a combination of vitamin D analogues and other agents |
Aug. 22, 2006 |
| 7094774 |
26,27-homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds |
Aug. 22, 2006 |
| 7094776 |
Method of locking 1.alpha.-OH of vitamin D compounds in axial orientation |
Aug. 22, 2006 |
| 7094916 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D.sub.3 and their uses |
Aug. 22, 2006 |
| 7074777 |
Vitamin D derivatives |
Jul. 11, 2006 |
| 7071344 |
Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
Jul. 4, 2006 |
| 7071179 |
Method of locking 1.alpha.-OH of vitamin D compounds in axial orientation |
Jul. 4, 2006 |
| 7064115 |
(20S)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin D.sub.3 and their uses |
Jun. 20, 2006 |
| 7056904 |
Method of locking 1.alpha.-OH of vitamin D compounds in axial orientation |
Jun. 6, 2006 |
| 7053075 |
Methods for reducing body fat using vitamin D compounds |
May. 30, 2006 |
| 6989377 |
Treating vitamin D responsive diseases |
Jan. 24, 2006 |
| 6982258 |
Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin D3 |
Jan. 3, 2006 |
| 6982257 |
Vitamin D3 derivative and its production method |
Jan. 3, 2006 |
|
|
|
